Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
FluoRok is revolutionizing the way fluorochemicals are produced globally.
Endlyz Therapeutics is developing disease-modifying therapeutics for Parkinson’s disease (PD) and other dementias.
First Light Fusion is an energy company that focuses on researching energy generation by inertial confinement fusion.
Ascension develops geothermal-based technologies for critical mineral recovery.
Archangel Lightworks builds deployable laser communication systems for the space-enabled networks of the future.
Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors.
Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.
Diffblue is a developer of automated testing software that enhances Java development by automatically generating unit tests.
Oxford University spin-out developing next-generation CSP and solar thermal storage technologies to decarbonise industrial heat processes
Software for mobile robots
SpyBiotech Operators of a biotechnology platform intended to generate next-generation vaccines.
PQShield is a post-quantum cryptography company that develops cryptographic algorithms and protocols to secure technology infrastructures.
Amber Therapeutics develops the next-generation of bioelectrical therapies.
Mind Foundry is an Oxford University company that has developed an AI platform to solve the world's most important problems.
Oxford VR is an evidence-based immersive treatment for serious mental illness and behavioral health.
Valink Therapeutics is a health care drug discovery for next-generation cancer treatments.
Wild Bioscience is a crop improvement company that provides carbon mitigation, yield enhancement, and farm productivity solutions.
Mode Labs provide robust, continuous, and remote real-time chemical sensors.
Seloxium is innovative research that makes it possible to extract necessary metals in an environmentally friendly manner.
Alloyed develops, licenses, and manufactures proprietary alloys, alloy powders and alloy components.
Mixergy offer a cost-effective solution to save energy and facilitate more renewable power generation.
Salience Labs offers photonic solutions designed to enhance connectivity for AI data center infrastructure.
Caristo Diagnostics is a biotech company that provides diagnostic platforms for heart diseases, stroke, and diabetes.
We are advancing novel antigen modulation technology that controls T cells to guide the immune system.
Oxford Science Enterprises has invested in 134 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Oxford Science Enterprises's top investment sectors include Biotechnology, Health Care, Therapeutics, Software, Manufacturing. The firm invests across 54 different industry categories.
Among tracked funding rounds, Wild Bioscience received $60.4M in a Series A round. Oxford Science Enterprises's total known invested capital is $2.2B.
Oxford Science Enterprises's average investment size is $18.0M across its portfolio of 134 companies.
Recent Oxford Science Enterprises portfolio additions include FluoRok, Endlyz Therapeutics, First Light Fusion, Ascension, Archangel Lightworks. These companies were founded in 2020 or later.